期刊文献+

乳腺癌治疗方法的革新与挑战 被引量:1

The challenges after innovations in breast cancer therapy
下载PDF
导出
摘要 随着乳腺癌治疗方法研究的进展与新方法的应用,发现了不少受学者们关注的问题,对肿瘤医师,包括乳腺外科医师、放射治疗医师和肿瘤内科医师都提出新的挑战。如因乳腺癌前哨淋巴结活检的准确性差异导致手术方法选择不当造成的后果,法律责任怎样承担的问题;保留乳房切除术后对传统的放射治疗方法带来新的挑战;新辅助化疗使原发肿瘤或/和转移淋巴结中的癌组织坏死,影响对手术切缘癌细胞浸润的判断和腋窝淋巴结转移真实性的判断,以及由此而带来的对放射治疗适应证的评判和放射治疗方法选择的影响;长时间服用三苯氧胺(TAM)等内分泌药物治疗导致子宫内膜增生、甚至癌变。这些都需要人们正确面对和重视,迎接新的挑战,解决新的问题。 With the progress of breast cancer researches, new ideas are constantly brought forth to improve the treatment methods. However, with the application of new methods, the oncologists, including breast surgeons, radiation therapists, and medical oncologists have to face new problems and challenges. For example, the poor accuracy of the sentinel lymph node biopsy for breast cancer may lead to the improper choice of operation method; breast-conserving surgery challenges the postoperative radiotherapy methods; the necrosis of the primary tumor tissue and/or metastatic lymph nodes after neoadjuvant chemotherapy affects the evaluation of the surgical margin status and the truthfulness of the axillary lymph node metastasis, and hence affects the judgment of the radiotherapy indications and the choice of the radiotherapy methods; long-term administration of tamoxifen (TAM) or other endocrine-involved drugs may lead to endometrial hyperplasia, even cancerization. We must take these problems seriously and take challenges actively to solve problems.
出处 《医学争鸣》 CAS 北大核心 2015年第6期17-21,共5页 Negative
基金 湖南省自然科学基金(11jj3122) 长沙市科技局资助项目(K1406035-11)
关键词 乳腺肿瘤 治疗 革新 挑战 breast cancer treatment innovation challenge
  • 相关文献

参考文献2

二级参考文献14

  • 1燕鑫,高雨农,蒋国庆,汤望舒.134例乳腺癌患者妇科并发症临床病理分析[J].中国妇产科临床杂志,2007,8(1):30-34. 被引量:3
  • 2Smith RE, Good BC. Chemoprevention of breast caneer and the trials of the National Surgical Adjuvant Breast and Bowel Project and others. Endocr Relat Cancer, 2003, 10:347- 357.
  • 3Cohen I. Endometrial pathologies associated with postmeno- pausal tamoxifen treatment. Gynecol Oncol, 2004, 94: 256- 266.
  • 4ACOG committee opinion. No. 336: Tamoxifen and uterine cancer. Obstet Gynecol, 2006, 107: 1475- 1478.
  • 5Garuti G, Cellani F, Centinaio G, et al. Baseline endometrial assessment before tamoxifen for breast cancer in asymptomatic menopausal women. Gynecol Oncol, 2005, 98:63 - 67.
  • 6Swerdlow AJ, Jones ME. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case- control study. J Natl Cancer Inst, 2005, 97: 375- 384.
  • 7Garuti G, Grossi F, Centinaio G, et al. Pretreatment and prospective assessment of endometrium in menopausal women taking tamoxifen for breast cancer. Eur J Obstet Gynecol Reprod Biol, 2007, 132: 101 - 106.
  • 8Le Donne M, Lentini M, De Meo L, et al. Uterine pathologies in patients undergoing tamoxifen therapy for breast cancer: ultrasonographic, hysteroscopic and histological findings. Eur J Gynaecol Oneol, 2005, 26:623 - 626.
  • 9Hernandez E. Endometrial adenocarcinoma: a primer for the generalist. Obstet Gynecol Clin North Am, 2001, 28:743- 757.
  • 10Cohen I. Aromatase inhibitors and the endometrium. Maturitas, 2008, 59:285-292.

共引文献17

同被引文献5

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部